Discussion & Questions From The Audience

 

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

 

Timing Question
00:00:00
  1. For recurrent desmoids or non-resectable desmoid tumors, do you like to see sorafenib as a first line or do you like to see chemotherapy as a first line?
00:05:00
  1. How do we monitor the neurocognitive effects of Avapritinib?
00:07:02
  1. For retroperitoneal, dedifferentiated liposarcoma, how long does the disease-free interval have to be to propose reoperating at the time of recurrence?
00:09:03
  1. How do you like to image such dedifferentiated liposarcomas to plan a surgical resection? Is it CT, is it MRI, is it some combination? Do you ever use FDG-PET?

 

[video_lightbox_youtube video_id=”zguO80uDHRg&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]

Click Here To Open Transcript



Q&A: Catching Up On Key Concepts

 

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

 

Timing Question
00:01:15
  1. After STRASS 1, the preoperative versus no preoperative radiotherapy for primary retroperitoneal sarcoma, the first-line treatment per the results of this trial is
00:04:30
  1. According to the global, Europe, Asia, America, Consensus-Based Guideline 2020 for desmoid fibromatosis, the first-line strategy of managing a desmoid, apart from any patient with a complication is?
00:07:25
  1. What is the main clinical feature of BCOR rearranged sarcomas?
00:09:33
  1. What of the following statements is correct (with reference to WHO classification)?
00:12:55
  1. Avapritinib was approved in 2020 for what type of sarcoma?
00:14:27
  1. Which of the following is false about NTRK fusions?

 

[video_lightbox_youtube video_id=”-TzWTZNfFeg&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]

Click Here To Open Transcript



Part 4: Through The Oncologist’s Eyes – George Demetri

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

[video_lightbox_youtube video_id=”c37cJBTkekA&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]
Click Here To Open Transcript



Part 3: What The Pathologist Focusses On – Angelo Paolo Dei Tos

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

[video_lightbox_youtube video_id=”Dg-Fv0UALMw&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]
Click Here To Open Transcript



Part 2: From The Surgeon’s Point Of View – Sylvie Bonvalot

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

[video_lightbox_youtube video_id=”sr4nyJ0WVB0&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]
Click Here To Open Transcript



Part 1: Welcome & Introduction – George Demetri

The following presentations may contain off-label content and data concerning products not currently registered in Australia. Specialised Therapeutics does not recommend or endorse off-label use or use of products that are not registered in Australia. These videos are intended for healthcare professionals for informative purposes only.

[video_lightbox_youtube video_id=”ZHlheozCiuQ&rel=0″ width=”1522″ height=”775″ anchor=”Click Here To Watch The Video”]
Click Here To Open Transcript